Experience

• 

  Aspire Pharmaceuticals

  • VP of Commercial Operations

    • Jun 2019 - Present

• 

  International Vitamin Corporation

  • Freehold NJ

  • VP of Operations

    • Apr 2014 - Jan 2019
    • Freehold NJ

    My responsibilities included—but were not limited to—manufacturing, packaging maintenance and engineering, inbound/outbound freight, and technical support. I was also charged with ensuring operations meet or exceed monthly financial requirements by satisfying demand and forecast with support from internal and external cross-functional groups.

• 

  PuraCap Pharmaceutical, LLC

  • South Plainfield, NJ

  • Vice President Of Global Operations

    • Apr 2011 - Apr 2014
    • South Plainfield, NJ

    My primary objective was to oversee the foundation, development, and operation of a state-of-the-art soft gelatin facility that adhered to all of the USFDA’s and China Food and Drug Administration’s (CFDA) guidelines and regulations. Once the facility had the necessary equipment and our USFDA audit was pending, my focus shifted to strengthening the facility’s operations by training staff, validating equipment, and authorizing processes.

• 

  International Vitamin Corporation

  • United States
  • Manufacturing
  • 400 - 500 Employee

  • Director Of Operations

    • May 2006 - Apr 2011

    I was tasked with working with the Research and Development team to develop and produce new products depending on demand and market trends. During my tenure, I improved profitability by increasing batch sizes on products that had high volume associated with low process/performance risk, all while putting emphasis on developing cross functional collaboration.

  • Plant Engineer

    • Mar 1997 - May 2006

    Primary functions included establishing procedures and parameters to maintain an upstart nutraceutical company, which we would soon transition into OTC and Rx company as well.

• 

  Banner Pharmacaps

  • Elizabeth, NJ

  • Facilities and Engineering

    • Jul 1984 - Mar 1997
    • Elizabeth, NJ

    Assisted in the transition from nutraceutical products to OTC and Rx, which included updating processes, sequencing, and machinery